The fully electronic BETACONNECT™ autoinjector automates the Betaferon® injection to provide a quiet and potentially more comfortable injection for MS patients who use Betaferon®.
The BETACONNECT auto-injector provides visual and audible injection reminders, and flexibility in injection depth and speed based on patient preferences. Betaferon® patients may choose to use BETACONNECT independently or as part of a complete software based system designed to track injection history and share important treatment information with healthcare providers. An application, called myBETAapp™, will provide Bluetooth or USB automated uploading of injection data and will allow patients to record other injection and general health information.
Users will be able to connect electronically across multiple platforms (Windows, Apple Mac OS X, iOS, Android) to provide continuous feedback and notifications to help Betaferon® patients achieve and maintain their treatment goals. Patients may choose to share information via the myBETAapp™ dashboard with healthcare providers.
The roll-out of the BETACONNECT™ autoinjector to patients who are on Betaferon® treatment to manage their MS has started in Europe with Germany as the first country. The BETACONNECT™ software (myBETAapp and Healthcare provider dashboard) is anticipated to be available in selected European countries in the fourth quarter, 2014.
Bang & Olufsen Medicom is the designer and developer behind the new BETACONNECT delivery system and will furthermore be the manufacturer. BETACONNECT received an Honourable Mention in this year’s Red Dot Award for Product Design.
"We are extremely proud to be able to show the world the innovative strength and high-end solution capabilities of Medicom. This will be a beacon solution in the injectable device world", says Morten Nielsen, CEO. "We strongly believe that the BETACONNECT delivery system will create distinct market differentiation for Bayer within MS", "We wish Bayer best of luck with the launch of the BETACONNECT system", Morten Nielsen concludes.
For more information, contact Morten Nielsen, CEO, Tel: +45 70 30 16 00.
BAYER, the Bayer Cross, Betaferon, BETACONNECT, myBETApp are registered trademarks of Bayer.